We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Joint Committee on Vaccination and Immunisation's (JCVI) final recommendations on changes to the childhood immunisation schedule.
An interim position statement about the use of Bexsero meningococcal B vaccine in the UK released by JCVI.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the groups that should be prioritised for vaccination.
The Joint Committee on Vaccination and Immunisation (JCVI) statement on vaccine dose prioritisation in response to the monkeypox outbreak.
Statements from the Joint Committee on Vaccination and Immunisation (JCVI) about use of Bexsero® meningococcal B vaccine in the UK.
Interim advice from the JCVI on the requirements for a potential COVID-19 booster vaccination programme for winter 2021 to 2022
JCVI statement setting out advice on the use of the 4CMenB vaccine for the prevention of gonorrhoea in those who are at increased risk of infection.
Statement setting out the advice from JCVI on the use of the MVA-BN vaccination for the prevention of mpox.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.
Statement setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the spring 2023 COVID-19 vaccination programme.
Conclusions on extending the human papillomavirus infection (HPV) vaccination programme to adolescent boys in the UK.
The Joint Committee on Vaccination and Immunisation has advised that the pneumococcal vaccination programme for those aged 65 years and older should stop.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).